Endocrinology
|
August 26, 2024

Estradiol Patches: Timeline for Effectiveness and What to Expect

Medically Reviewed by
Updated On
September 17, 2024

The history of hormone replacement therapy started in the 1960s, vastly increasing in popularity in the 1990s, then sought a decline after 2002 due to a study by the Women's Health Initiative (WIH). The study published the potential risks of estrogen and progestin therapy in increasing women’s risk of heart disease and breast cancer. After this was publicized in the media, many women shied away from hormonal replacement treatment. 

However, evidence since then suggests these results are not as alarming as they originally appeared. We are now seeing a gradual increase in the use of hormone replacement therapy, especially in younger women with troublesome symptoms. 

Experts argue that for women under the age of 60 with perimenopausal and postmenopausal symptoms, the benefits may outweigh the risks. Understanding the benefits, risks, and timeline of estradiol patches, a form of hormone replacement therapy can help set realistic expectations and ensure effective management of symptoms. 

[signup]

What is Estradiol and How Do Estradiol Patches Work?

Hormonal replacement therapy, with the administration of estrogen, progesterone, and/or testosterone, can alleviate symptoms such as hot flashes and night sweats, vaginal symptoms, sleep disturbances, and mood changes, and may even help prevent long-term health issues such as osteoporosis and support cardiovascular health

Estradiol, a form of estrogen, is a critical hormone in the function and development of female and male reproductive systems. It regulates the menstrual cycle by promoting the growth of the uterine lining, triggers luteinizing hormone for ovulation, and supports the fetus throughout pregnancy. 

Estrogen regulates the distribution of body fat in females and is essential for breast development. It also has neuroprotective properties, including regulating mood and cognitive function

An important function of estrogen is its influence on the acid pH in the vaginal canal, with normal ranges between 4.5-6.0. Estrogen decreases vaginal pH. In menopause and postmenopause, with this decrease of estrogen, there is an alkalinization of the vaginal canal to about 6.5-7.0. A vaginal pH of greater than 6.5 correlates with an increased risk of vaginal infections and symptoms such as dyspareunia (pain during sex), urinary tract infections, vaginal itching, and vaginal dryness. 

Postmenopausal women are at a higher risk of osteoporosis or when bones become weak and brittle. This is due to the estrogen decline in menopause. Estradiol helps maintain bone density by inhibiting bone breakdown. 

Estradiol has a vasodilating effect, which helps maintain healthy blood pressure levels and has an impact on maintaining healthy cholesterol levels, reducing cardiovascular risk. 

Estradiol transdermal patches deliver hormones transdermally (through the skin). When the patch is applied, estradiol diffuses from the patch into the epidermis (the upper skin layer), then makes its way into the deeper dermis. From the dermis, estradiol is absorbed into the bloodstream through the capillaries, providing its effects throughout the body. 

With this absorption type, estradiol bypasses the liver initially, leading to higher bioavailability and potentially lower doses needed for an optimal effect. It also avoids the gastrointestinal tract, reducing the risk of gastrointestinal side effects compared to oral forms of estrogen. 

Patches are typically changed once or twice a week, which may be more convenient for some than taking an oral formulation. They provide a more continuous release of estradiol, leading to more stable blood hormone levels. 

There is evidence that transdermal estradiol may carry a lower risk of thromboembolism or blood clots than oral forms. 

Expected Timeline for Estradiol Patches to Start Working

Transdermal estrogen patches can cause an improvement in symptoms within two weeks. The time it takes for symptom relief can vary amongst patients and symptoms. It normally takes 11-13 hours for the body to metabolize through a patch. However, there may be variations based on body weight. 

Data from several studies suggested that estrogen replacement therapy had antidepressant effects or that it enhanced the effects of antidepressant treatment in perimenopausal women. 

Mood symptoms may take up to a few months for symptom relief. Research has shown that the use of estradiol can decrease stress by reducing the release of cortisol in response to a physical stressor. Mood and sleep improvements may take a few weeks to months.

A study conducted over 12 months found vasomotor symptoms of menopause (hot flashes, night sweats, heart palpitations, changes in blood pressure) improved by 73% in perimenopausal women with the use of transdermal estradiol. 

Some people may experience skin irritation at the site of transdermal patch application. Rotating location sites is recommended to reduce this risk. For optimal application, it’s best to avoid lotion or oils in the area where a patch will be applied to avoid adhesion issues. 

Within the first week of use, patients may experience symptoms contributing to the new influx of estrogen, such as headaches or breast tenderness, as well as being more emotional or irritable. If a patient still has a menstrual cycle, periods may be lighter, heavier, or irregular as the body adjusts.  

Factors Influencing the Effectiveness of Estradiol Patches

Absorption rates can vary between individuals and between different estrogen patches. Variations in estrogen patches include the type of estrogen used and the design. A person’s skin quality, age, body weight, and metabolism are all factors that could affect absorption rates. 

It’s important to follow estrogen patch application recommendations, such as rotating patch sights, to maximize its effectiveness and maintain skin health. The skin should be clean and dry, and the patch should be placed in an area with less oil production and hair growth. Patch replacements should be performed as recommended, as not following a schedule can disrupt hormone levels. 

Examples of FDA-Approved Estradiol Transdermal Patches

  • Climara 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied once weekly 
  • Esclim 0.025, 0.0375, 0.075, 0.1 mg/day applied twice weekly
  • Fempatch 0.025 mg/day applied once weekly
  • Menostar 0.014 mg/day applied once weekly
  • Vivelle 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied twice weekly
  • Vivelle Dot 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied twice weekly 

Individuals must seek guidance in hormone replacement therapy from trained and experienced healthcare professionals. These professionals may make adjustments necessary to optimize effectiveness based on each individual’s personal responses. 

Monitoring and Evaluating Effectiveness

Patients keeping a symptoms diary can help provide healthcare hormone experts with valuable information and a clearer picture of their symptoms, response, and overall journey with estrogen patches and hormone replacement therapy.

Key symptoms important to record include:

  • Sleep quality
  • Stress levels based on a 1-10 scale 
  • Mood, anxiety, depression, and irritability
  • Hot flashes, night sweats
  • Vaginal dryness, itching, irritation
  • Pain with sexual intercourse
  • Hair texture changes, hair growth or loss 
  • Joint pain and swelling 
  • Low libido
  • Brain fog, concentration 

Regular check-ups with health care professionals are crucial in optimizing hormone levels, evaluating effectiveness, monitoring risk and long-term health, and managing side effects. Hormone replacement therapy must be tailored to every individual's needs, medical history, and symptoms. A risk versus benefit analysis is vital to be performed on all patients. 

Other Lab Tests and Biomarkers to Test

Monitoring blood hormone levels before and throughout treatment is essential to obtain baseline values, along with monitoring hormone replacement progress. Balancing the body’s hormonal balance is an intricate process that will differ based on every patient’s specific needs. 

Blood hormone levels to consider ordering in evaluating patients for hormone replacement therapy include:

Monitoring bone health is especially important in postmenopausal women due to the elevated risk of developing osteoporosis and related complications such as bone fractures. Early detection of risks can be prevented through the use of bone density scans or DEXA scans. 

Current recommendations of DEXA scans include screening every woman over the age of 65. All postmenopausal women over the age of 50 should be assessed for osteoporosis risk, with risk factors such as a family history of osteoporosis, history of previous fractures, long-term steroid use, or smoking. Women with osteoporosis should be monitored more closely, with scanning every 1-2 years. 

As discussed previously in this article, the decrease in estrogen in menopausal and postmenopausal patients can increase the risk of cardiovascular disease. Monitoring lipid profiles to assess these patients' cardiovascular health is essential.

Blood glucose, fasting insulin, and hemoglobin A1c levels should also be considered in this patient population, as a woman's metabolism undergoes several changes in menopause. Menopause can lead to changes in how the body processes glucose, potentially increasing insulin resistance and increasing the risk of type 2 diabetes

[signup]

Key Takeaways

  • The expected timeline of symptom relief with estradiol patches will vary depending on every individual and the symptoms they are experiencing. Symptom relief can first be experienced within a couple of weeks,  with hormone optimization taking up to 6 months.
  • Hormone replacement therapy is extremely personalized, with varying dosages and formulations available. Patients can optimize effectiveness by following recommended protocols and application processes. 
  • Regular monitoring of hormone replacement is crucial to evaluate effectiveness and safety to reach health optimization and disease prevention. Patients are encouraged to consult with specialized hormone healthcare providers for tailored treatment plans to their personal needs and goals, which may also include lifestyle changes.  

The history of hormone replacement therapy started in the 1960s, vastly increasing in popularity in the 1990s, then sought a decline after 2002 due to a study by the Women's Health Initiative (WIH). The study published the potential risks of estrogen and progestin therapy in increasing women’s risk of heart disease and breast cancer. After this was publicized in the media, many women shied away from hormonal replacement treatment. 

However, evidence since then suggests these results are not as alarming as they originally appeared. We are now seeing a gradual increase in the use of hormone replacement therapy, especially in younger women with troublesome symptoms. 

Experts argue that for women under the age of 60 with perimenopausal and postmenopausal symptoms, the benefits may outweigh the risks. Understanding the benefits, risks, and timeline of estradiol patches, a form of hormone replacement therapy, can help set realistic expectations and ensure effective management of symptoms. 

[signup]

What is Estradiol and How Do Estradiol Patches Work?

Hormonal replacement therapy, with the administration of estrogen, progesterone, and/or testosterone, can help alleviate symptoms such as hot flashes and night sweats, vaginal symptoms, sleep disturbances, and mood changes, and may even support long-term health by helping to maintain bone density and cardiovascular health. 

Estradiol, a form of estrogen, is a critical hormone in the function and development of female and male reproductive systems. It regulates the menstrual cycle by promoting the growth of the uterine lining, triggers luteinizing hormone for ovulation, and supports the fetus throughout pregnancy. 

Estrogen regulates the distribution of body fat in females and is essential for breast development. It also has properties that may support mood and cognitive function

An important function of estrogen is its influence on the acid pH in the vaginal canal, with normal ranges between 4.5-6.0. Estrogen decreases vaginal pH. In menopause and postmenopause, with this decrease of estrogen, there is an alkalinization of the vaginal canal to about 6.5-7.0. A vaginal pH of greater than 6.5 correlates with an increased risk of vaginal infections and symptoms such as dyspareunia (pain during sex), urinary tract infections, vaginal itching, and vaginal dryness. 

Postmenopausal women are at a higher risk of osteoporosis or when bones become weak and brittle. This is due to the estrogen decline in menopause. Estradiol helps maintain bone density by inhibiting bone breakdown. 

Estradiol has a vasodilating effect, which may help maintain healthy blood pressure levels and support healthy cholesterol levels, potentially reducing cardiovascular risk. 

Estradiol transdermal patches deliver hormones transdermally (through the skin). When the patch is applied, estradiol diffuses from the patch into the epidermis (the upper skin layer), then makes its way into the deeper dermis. From the dermis, estradiol is absorbed into the bloodstream through the capillaries, providing its effects throughout the body. 

With this absorption type, estradiol bypasses the liver initially, leading to higher bioavailability and potentially lower doses needed for an optimal effect. It also avoids the gastrointestinal tract, reducing the risk of gastrointestinal side effects compared to oral forms of estrogen. 

Patches are typically changed once or twice a week, which may be more convenient for some than taking an oral formulation. They provide a more continuous release of estradiol, leading to more stable blood hormone levels. 

There is evidence that transdermal estradiol may carry a lower risk of thromboembolism or blood clots than oral forms. 

Expected Timeline for Estradiol Patches to Start Working

Transdermal estrogen patches can cause an improvement in symptoms within two weeks. The time it takes for symptom relief can vary amongst patients and symptoms. It normally takes 11-13 hours for the body to metabolize through a patch. However, there may be variations based on body weight. 

Data from several studies suggested that estrogen replacement therapy had mood-supporting effects or that it enhanced the effects of mood treatments in perimenopausal women. 

Mood symptoms may take up to a few months for symptom relief. Research has shown that the use of estradiol can help manage stress by reducing the release of cortisol in response to a physical stressor. Mood and sleep improvements may take a few weeks to months.

A study conducted over 12 months found vasomotor symptoms of menopause (hot flashes, night sweats, heart palpitations, changes in blood pressure) improved by 73% in perimenopausal women with the use of transdermal estradiol. 

Some people may experience skin irritation at the site of transdermal patch application. Rotating location sites is recommended to reduce this risk. For optimal application, it’s best to avoid lotion or oils in the area where a patch will be applied to avoid adhesion issues. 

Within the first week of use, patients may experience symptoms contributing to the new influx of estrogen, such as headaches or breast tenderness, as well as being more emotional or irritable. If a patient still has a menstrual cycle, periods may be lighter, heavier, or irregular as the body adjusts.  

Factors Influencing the Effectiveness of Estradiol Patches

Absorption rates can vary between individuals and between different estrogen patches. Variations in estrogen patches include the type of estrogen used and the design. A person’s skin quality, age, body weight, and metabolism are all factors that could affect absorption rates. 

It’s important to follow estrogen patch application recommendations, such as rotating patch sights, to maximize its effectiveness and maintain skin health. The skin should be clean and dry, and the patch should be placed in an area with less oil production and hair growth. Patch replacements should be performed as recommended, as not following a schedule can disrupt hormone levels. 

Examples of FDA-Approved Estradiol Transdermal Patches

  • Climara 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied once weekly 
  • Esclim 0.025, 0.0375, 0.075, 0.1 mg/day applied twice weekly
  • Fempatch 0.025 mg/day applied once weekly
  • Menostar 0.014 mg/day applied once weekly
  • Vivelle 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied twice weekly
  • Vivelle Dot 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied twice weekly 

Individuals must seek guidance in hormone replacement therapy from trained and experienced healthcare professionals. These professionals may make adjustments necessary to optimize effectiveness based on each individual’s personal responses. 

Monitoring and Evaluating Effectiveness

Patients keeping a symptoms diary can help provide healthcare hormone experts with valuable information and a clearer picture of their symptoms, response, and overall journey with estrogen patches and hormone replacement therapy.

Key symptoms important to record include:

  • Sleep quality
  • Stress levels based on a 1-10 scale 
  • Mood, anxiety, depression, and irritability
  • Hot flashes, night sweats
  • Vaginal dryness, itching, irritation
  • Pain with sexual intercourse
  • Hair texture changes, hair growth or loss 
  • Joint pain and swelling 
  • Low libido
  • Brain fog, concentration 

Regular check-ups with health care professionals are crucial in optimizing hormone levels, evaluating effectiveness, monitoring risk and long-term health, and managing side effects. Hormone replacement therapy must be tailored to every individual's needs, medical history, and symptoms. A risk versus benefit analysis is vital to be performed on all patients. 

Other Lab Tests and Biomarkers to Test

Monitoring blood hormone levels before and throughout treatment is essential to obtain baseline values, along with monitoring hormone replacement progress. Balancing the body’s hormonal balance is an intricate process that will differ based on every patient’s specific needs. 

Blood hormone levels to consider ordering in evaluating patients for hormone replacement therapy include:

Monitoring bone health is especially important in postmenopausal women due to the elevated risk of developing osteoporosis and related complications such as bone fractures. Early detection of risks can be supported through the use of bone density scans or DEXA scans. 

Current recommendations of DEXA scans include screening every woman over the age of 65. All postmenopausal women over the age of 50 should be assessed for osteoporosis risk, with risk factors such as a family history of osteoporosis, history of previous fractures, long-term steroid use, or smoking. Women with osteoporosis should be monitored more closely, with scanning every 1-2 years. 

As discussed previously in this article, the decrease in estrogen in menopausal and postmenopausal patients can increase the risk of cardiovascular disease. Monitoring lipid profiles to assess these patients' cardiovascular health is essential.

Blood glucose, fasting insulin, and hemoglobin A1c levels should also be considered in this patient population, as a woman's metabolism undergoes several changes in menopause. Menopause can lead to changes in how the body processes glucose, potentially increasing insulin resistance and increasing the risk of type 2 diabetes

[signup]

Key Takeaways

  • The expected timeline of symptom relief with estradiol patches will vary depending on every individual and the symptoms they are experiencing. Symptom relief can first be experienced within a couple of weeks,  with hormone optimization taking up to 6 months.
  • Hormone replacement therapy is extremely personalized, with varying dosages and formulations available. Patients can optimize effectiveness by following recommended protocols and application processes. 
  • Regular monitoring of hormone replacement is crucial to evaluate effectiveness and safety to reach health optimization and disease prevention. Patients are encouraged to consult with specialized hormone healthcare providers for tailored treatment plans to their personal needs and goals, which may also include lifestyle changes.  
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

By the way, Doctor: Is the ultra-low dose estrogen patch available? (2014, March 9). Harvard Health. https://www.health.harvard.edu/womens-health/by-the-way-doctor-is-the-ultra-low-dose-estrogen-patch-available

Cagnacci, A., & Venier, M. (2019). The Controversial History of Hormone Replacement Therapy. Medicina, 55(9). https://doi.org/10.3390/medicina55090602

Cleveland Clinic. (2020). DEXA Scan (DXA): Bone Density Test, What Is It & How It’s Done. Cleveland Clinic. https://my.clevelandclinic.org/health/diagnostics/10683-dexa-dxa-scan-bone-density-test

Climara Pro®: Official patient website. (n.d.). Home. Retrieved July 5, 2024, from https://www.climarapro.com

Cloyd, J. (2023a, July 13). A Functional Medicine UTI Protocol: Specialized Testing, Therapeutic Diet, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-uti-protocol-specialized-testing-therapeutic-diet-and-supplements

Cloyd, J. (2023b, August 9). A Root Cause Medicine Protocol for Patients With Depression: Comprehensive Lab Testing, Therapeutic Diet, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-depression-comprehensive-lab-testing-therapeutic-diet-and-supplements

Cloyd, J. (2024, February 27). Sleep Requirements by Age Group & Why It’s Important. Rupa Health. https://www.rupahealth.com/post/sleep-requirements-by-age-group-why-its-important

Cloyd, K. (2023, October 25). Osteoporosis and Hormones: The Hidden Relationship Women Must Understand. Rupa Health. https://www.rupahealth.com/post/osteoporosis-and-hormones-the-hidden-relationship-women-must-understand

Coleman, E. (2024, May 31). 8 Natural Ways to Boost Estrogen: Diet, Lifestyle & More. Rupa Health. https://www.rupahealth.com/post/increase-estrogen-naturally

Craig, K. W., & Stevermer, J. J. (2012). DEXA screening--are we doing too much? The Journal of Family Practice, 61(9), 555–556. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601689/

DHEA-S. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/dhea-s

Esclim (Estradiol Transdermal): Side Effects, Uses, Dosage, Interactions, Warnings. (n.d.). RxList. Retrieved July 5, 2024, from https://www.rxlist.com/esclim-drug.htm

Estradiol. (n.d.). Rupa Health. Retrieved July 5, 2024, from https://www.rupahealth.com/biomarkers/e2#:~:text=It%20helps%20maintain%20bone%20health

FemPatch | CenterWatch. (n.d.). Www.centerwatch.com. Retrieved July 5, 2024, from https://www.centerwatch.com/directories/1067-fda-approved-drugs/listing/3522-fempatch

Follicle-Stimulating Hormone. (n.d.). Rupa Health. Retrieved July 5, 2024, from https://www.rupahealth.com/biomarkers/fsh#:~:text=Testing%20for%20follicle%2Dstimulating%20hormone

Free Thyroxine. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/ft4

Gambacciani, M., & Levancini, M. (2014). Featured Editorial Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Menopausal Review, 13(4), 213–220. https://doi.org/10.5114/pm.2014.44996

Ginsburg, E. S., Gao, X., Shea, B. F., & Barbieri, R. L. (1998). Half-Life of Estradiol in Postmenopausal Women. Gynecologic and Obstetric Investigation, 45(1), 45–48. https://doi.org/10.1159/000009923

Goldštajn, M. Š., Mikuš, M., Ferrari, F. A., Bosco, M., Uccella, S., Noventa, M., Török, P., Terzic, S., Laganà, A. S., & Garzon, S. (2022). Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review. Archives of Gynecology and Obstetrics, 307(6). https://doi.org/10.1007/s00404-022-06647-5

Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015). Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiological Reviews, 95(3), 785–807. https://doi.org/10.1152/physrev.00036.2014

Hariri, L., & Rehman, A. (2020). Estradiol. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549797/

Harper-Harrison, G., & Shanahan, M. M. (2024). Hormone Replacement Therapy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493191/#:~:text=Go%20to%3A-

Hemoglobin A1C | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/hba1c#:~:text=Hemoglobin%20A1c%20(HbA1c)%2C%20also

Hodis, H. N., & Mack, W. J. (2022). Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease. The Cancer Journal, 28(3), 208–223. https://doi.org/10.1097/ppo.0000000000000591

How to Interpret Your Lipid Panel Results. (2023, December 19). Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-lipid-panel-results#:~:text=A%20lipid%20panel%20is%20a

HRT for osteoporosis - Hormone replacement therapy | ROS. (2022, May). Theros.org.uk. https://theros.org.uk/information-and-support/osteoporosis/treatment/hormone-replacement-therapy/

Khan, S., & Sharman, T. (2024). Transdermal Medications. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556035/#:~:text=Hold%20or%20press%20the%20patch

Luteinizing Hormone. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/lh

Maholy, N. (2023, February 17). A functional medicine approach to anxiety: Testing, nutrition, & supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-anxiety

Mair, K. M., Gaw, R., & MacLean, M. R. (2020). Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension. Pulmonary Circulation, 10(3), 204589402095201. https://doi.org/10.1177/2045894020952023

Majumdar, S. R. (2004). Promotion and Prescribing of Hormone Therapy After Report of Harm by the Women’s Health Initiative. JAMA, 292(16), 1983. https://doi.org/10.1001/jama.292.16.1983

Menopause - Treatment. (2017, October 23). Nhs.uk. https://www.nhs.uk/conditions/menopause/treatment/#:~:text=Benefits%20of%20HRT&text=Hot%20flushes%20or%20night%20sweats

News: Hormone Replacement Skin Patches Don’t... (The New York Times) - Behind the headlines - NLM. (n.d.). NCBI. Retrieved July 5, 2024, from https://www.ncbi.nlm.nih.gov/search/research-news/2958#:~:text=Hormone%20Replacement%20Skin%20Patches%20Don

Phan, R. (2012, September 7). Estrogen Patches: What You Should Know. GoodRx; GoodRx. https://www.goodrx.com/estradiol/patch-over-pill

Progesterone. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/progesterone

Sex Hormone-Binding Globulin. (n.d.). Rupa Health. Retrieved July 5, 2024, from https://www.rupahealth.com/biomarkers/shbg#:~:text=Sex%20Hormone%20Binding%20Globulin%20(SHBG

Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. (n.d.). Read by QxMD. Retrieved July 5, 2024, from https://read.qxmd.com/read/12900318/short-term-use-of-estradiol-for-depression-in-perimenopausal-and-postmenopausal-women-a-preliminary-report?redirected=slug

Shulman, L. P., & Harari, D. (2004). Low-dose transdermal estradiol for symptomatic perimenopause. Menopause, 11(1), 34–39. https://doi.org/10.1097/01.gme.0000074705.98544.16

Sweetnich, J. (2023a, February 22). An Integrative Medicine Approach to Estradiol Imbalance. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-estradiol-imbalance

Sweetnich, J. (2023b, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Testosterone. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/testosterone

Thyroglobulin Antibodies. (n.d.). Rupa Health. Retrieved July 5, 2024, from https://www.rupahealth.com/biomarkers/anti-tg

Thyroid Peroxidase Antibodies. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/anti-tpo

Thyroid-Stimulating Hormone. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/tsh

Total Triiodothyronine. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/t3

Valdes, A., & Bajaj, T. (2020). Estrogen Therapy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK541051/

Viswanathan, M., Reddy, S., Berkman, N., Cullen, K., Middleton, J. C., Nicholson, W. K., & Kahwati, L. C. (2018, June 1). Table 1, Recommendations About Screening and Treatment of Osteoporosis From Various Professional and Health Organizations. Www.ncbi.nlm.nih.gov. https://www.ncbi.nlm.nih.gov/books/NBK532080/table/table1/

Vivelle ®. (n.d.). Retrieved July 5, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20323S21LBL.PDF

Vivelle-Dot ® (estradiol transdermal system) Continuous delivery for twice-weekly application Rx only Prescribing Information. (n.d.). https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20538slr019_vivelle_lbl.pdf

What is Insulin Resistance and What is the Effect on the Body? (2024, May 22). Rupa Health. https://www.rupahealth.com/post/what-is-insulin-resistance-effects

White, R. E. (2002). Estrogen and vascular function. Vascular Pharmacology, 38(2), 73–80. https://doi.org/10.1016/s0306-3623(02)00129-5

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Endocrinology
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.